Tudor Investment Corp’s IN8bio INAB Stock Holding History

Tudor Investment Corp’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,110	Closed	-$434K	–	2692
2021 Q3	$434K	Buy	+2,110	New	+$525K	0.01%	1753

Other funds holding INAB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Tudor Investment Corp's INAB Position: Q4 2021 in Review

Tudor Investment Corp sold out of IN8bio (INAB) in Q4 2021, closing a stake of 2,110 shares — an estimated $434K sold.

Tudor Investment Corp first reported a position in INAB in Q3 2021 and held it in 1 quarter. The position peaked at $434K in Q3 2021. 13 funds tracked by Wall St. Rank hold INAB as of Q4 2021.

Tudor Investment Corp reported no remaining IN8bio position as of Q4 2021 after selling out during the quarter.
Tudor Investment Corp sold 2,110 IN8bio shares in Q4 2021, an estimated $434K.
Tudor Investment Corp first reported a position in IN8bio in Q3 2021 and held it in 1 quarter.
Tudor Investment Corp's IN8bio position peaked at $434K in Q3 2021.
13 funds tracked by Wall St. Rank held IN8bio as of Q4 2021.

Based on Tudor Investment Corp's 13F filing for Q4 2021, filed 14 Feb 2022.